AAAAAA

   
Results: 1-14 |
Results: 14
No evidence of accelerated loss of kidney function in living kidney donors: Results from a cross-sectional follow-up
Authors: Fehrman-Ekholm, I Duner, F Brink, B Tyden, G Elinder, CG
Citation: I. Fehrman-ekholm et al., No evidence of accelerated loss of kidney function in living kidney donors: Results from a cross-sectional follow-up, TRANSPLANT, 72(3), 2001, pp. 444-449
Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients
Authors: Squifflet, JP Backman, L Claesson, K Dietl, KH Ekberg, H Forsythe, JLR Kunzendorf, U Heemann, U Land, W Morales, JM Muhlbacher, F Talbot, D Taube, D Tyden, G van Hooff, J Schleibner, S Vanrenterghem, Y
Citation: Jp. Squifflet et al., Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients, TRANSPLANT, 72(1), 2001, pp. 63-69
The use of pretransplant erythropoietin to normalize hemoglobin levels hasno deleterious effects on renal transplantation outcome
Authors: Linde, T Ekberg, H Forslund, T Furuland, H Holdaas, H Nyberg, G Tyden, G Wahlberg, J Danielson, BG
Citation: T. Linde et al., The use of pretransplant erythropoietin to normalize hemoglobin levels hasno deleterious effects on renal transplantation outcome, TRANSPLANT, 71(1), 2001, pp. 79-82
Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis
Authors: Ekberg, H Backman, L Tufveson, G Tyden, G Nashan, B Vincenti, F
Citation: H. Ekberg et al., Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis, TRANSPLAN I, 13(2), 2000, pp. 151-159
Combined pancreas and kidney transplantation improves survival in patientswith end-stage diabetic nephropathy
Authors: Tyden, G Tollemar, J Bolinder, J
Citation: G. Tyden et al., Combined pancreas and kidney transplantation improves survival in patientswith end-stage diabetic nephropathy, CLIN TRANSP, 14(5), 2000, pp. 505-508
Polyomaviruria in renal transplant patients is not correlated to the cold ischemia period or to rejection episodes
Authors: Priftakis, P Bogdanovic, G Tyden, G Dalianis, T
Citation: P. Priftakis et al., Polyomaviruria in renal transplant patients is not correlated to the cold ischemia period or to rejection episodes, J CLIN MICR, 38(1), 2000, pp. 406-407
Development of renal cell carcinoma in living donor kidney grafts
Authors: Tyden, G Wernersson, A Sandberg, J Berg, U
Citation: G. Tyden et al., Development of renal cell carcinoma in living donor kidney grafts, TRANSPLANT, 70(11), 2000, pp. 1650-1652
Area under the serum creatinine time-curve is a strong predictor of chronic renal allograft rejection
Authors: Setterberg, L Elinder, CG Fored, CM Tyden, G Reinholt, FP
Citation: L. Setterberg et al., Area under the serum creatinine time-curve is a strong predictor of chronic renal allograft rejection, TRANSPLANT, 69(5), 2000, pp. 964-968
Renal transplantation in patients with urinary diversion: a case-control study
Authors: Warholm, C Berglund, J Andersson, J Tyden, G
Citation: C. Warholm et al., Renal transplantation in patients with urinary diversion: a case-control study, NEPH DIAL T, 14(12), 1999, pp. 2937-2940
Tacrolimus whole blood concentrations correlate closely to side-effects inrenal transplant recipients
Authors: Bottiger, Y Brattstrom, C Tyden, G Sawe, J Groth, CG
Citation: Y. Bottiger et al., Tacrolimus whole blood concentrations correlate closely to side-effects inrenal transplant recipients, BR J CL PH, 48(3), 1999, pp. 445-448
Zenapax (daclizumab) reduces the incidence of acute rejection episodes andimproves patient survival following renal transplantation
Authors: Ekberg, H Backman, L Tufveson, G Tyden, G
Citation: H. Ekberg et al., Zenapax (daclizumab) reduces the incidence of acute rejection episodes andimproves patient survival following renal transplantation, TRANSPLAN P, 31(1-2), 1999, pp. 267-268
Improved survival in patients with insulin-dependent diabetes mellitus andend-stage diabetic nephropathy 10 years after combined pancreas and kidneytransplantation.
Authors: Tyden, G Bolinder, J Solders, G Brattstrom, C Tibell, A Groth, CG
Citation: G. Tyden et al., Improved survival in patients with insulin-dependent diabetes mellitus andend-stage diabetic nephropathy 10 years after combined pancreas and kidneytransplantation., TRANSPLANT, 67(5), 1999, pp. 645-648
Hypertriglyceridemia in renal transplant recipients treated with sirolimus
Authors: Brattstrom, C Wilczek, HE Tyden, G Bottiger, Y Sawe, J Groth, CG
Citation: C. Brattstrom et al., Hypertriglyceridemia in renal transplant recipients treated with sirolimus, TRANSPLAN P, 30(8), 1998, pp. 3950-3951
Islet autoimmunity before and after pancreas transplantation in patients with Type I diabetes mellitus
Authors: Sundkvist, G Tyden, G Karlsson, FA Bolinder, J
Citation: G. Sundkvist et al., Islet autoimmunity before and after pancreas transplantation in patients with Type I diabetes mellitus, DIABETOLOG, 41(12), 1998, pp. 1532-1533
Risultati: 1-14 |